Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ming capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 5
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees 2

Areas of investment

  • Medical Device
  • Medical
  • Health Care
  • Health Diagnostics
  • Personal Health
Summary

The company was established in Asia in China. The main office of represented VC is situated in the Shenzhen.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Apps, Human Computer Interaction. Among the most popular portfolio startups of the fund, we may highlight Miracor Medical, 0glass. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Ming capital, startups are often financed by SHS Gesellschaft fur Beteiligungsmanagement, Earlybird Venture Capital, Delta Partners. The meaningful sponsors for the fund in investment in the same round are SFPI-FPIM, Meusinvest, SHS Gesellschaft fur Beteiligungsmanagement. In the next rounds fund is usually obtained by Yungpark Lingzhong Fund, SFPI-FPIM, Quest for Growth.

The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Ming capital:
Typical Co-investors
Ming capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Ming capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
7cool China, Jiangsu, Wuxi Shi
Adour Business Angels Aquitaine, France, Pau
Asclepios Biosearch England, London, United Kingdom
Atom Ventures China, Jingan, Shanghai
Communitech HYPERDRIVE Canada, Kitchener, Ontario
Dezheng Touzi China, Guangdong, Guangzhou
Guangdong Bobaolon China, Guangdong Province, Jieyang City
Horizon Capital -
InvestHER Ventures Chicago, Illinois, United States
Lionheart Ventures California, San Francisco, United States
Matthew Pritzker Company Chicago, Illinois, United States
MOHARA England, London, United Kingdom
Puhua Jingxin Guzhou Health -
Quayle Munro England, London, United Kingdom
Shanghai Liuhe Capital China, Shanghai
Shengyu Jiatian Beijing, Beijing, China
Strattech Partners Devon, Pennsylvania, United States
SWAN Venture Fund Kirkland, United States, Washington
Utah Angels 2 -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Binhui Biotech

Biotechnology
$46M19 Apr 2022 Wuhan, Hubei, China

Gene Vector

Biotechnology
Genetics
$3M10 Mar 2022 Chengdu, Sichuan, China

CareTaker Medical

Health Care
Medical
Medical Device
02 Jun 2020 Virginia, United States

Miracor Medical

Health Care
Health Diagnostics
Medical
Medical Device
Personal Health
$5M04 Sep 2018 Belgium, Liège, Belgium

Miracor Medical

Health Care
Health Diagnostics
Medical
Medical Device
Personal Health
$29M04 Jan 2018 Belgium, Liège, Belgium

0glass

Apps
Artificial Intelligence
Human Computer Interaction
Optical Communication
Software
$1M18 May 2017 Guangdong Province

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ming capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: